Manufacture

How can we maximize the potential and production of potentially life-saving therapies?

How a holistic approach to horseshoe crab sustainability will allow the industry to maintain stocks while protecting patients.

Lonza and Cytena combine expertise to allow biotherapeutic manufacturers to benefit from the advantages of Pichia pastoris as an expression system.

Global regulators attended a virtual workshop on second generation COVID-19 vaccines – here’s what they talked about.

Bringing customized medicines to patients with additive manufacturing.

Edd Stone of TTP explains how the industry is overcoming the manufacturing challenges associated with cell therapies.

What role can regulators play in overcoming the barriers to the adoption of continuous manufacturing processes?

Creating a patient-centric ecosystem in India.

Why is there a need for innovation in cell line development technology?

How do we reduce the presence of pharmaceuticals in water?